Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
Rotavirus
2022
2014
Europe
Clear all
Type of publications
NITAG documentation
(36)
Systematic reviews (SYSVAC)
(9)
Topics
Available to download in languages
Regions
Europe
(45)
Africa
(23)
Eastern Mediterranean
(3)
South-East Asia
(2)
Western Pacific
(19)
Countries
Belgium
(5)
France
(15)
Germany
(2)
Ireland
(4)
Italy
(1)
Netherlands
(2)
Spain
(2)
Switzerland
(1)
Ukraine
(1)
United Kingdom
(7)
Diseases
COVID-19
(34)
Meningococcal disease
(8)
Rotavirus
(3)
Diphtheria
(3)
Hepatitis B
(3)
Herpes zoster
(3)
Human papillomavirus (HPV)
(11)
Influenza
(11)
Measles
(1)
Mpox // Monkeypox
(8)
Pertussis
(5)
Pneumococcal disease
(5)
Poliomyelitis
(2)
Rabies
(1)
Tetanus
(1)
Yellow fever
(1)
Vaccine topics
Acceptance
(4)
Coverage
(5)
Economic aspects
(1)
Efficacy/effectiveness
(1)
Ethical issues
(4)
Target population
Adolescents
(1)
Adults
(1)
All age groups
(7)
Children
(2)
Healthcare workers
(3)
Newborn
(2)
Older adults
(1)
Parents/caregivers
(2)
Pregnant women
(1)
Travellers
(1)
Publication date
2022
(37)
2014
(8)
2024
(1)
2023
(15)
2021
(77)
2020
(17)
2019
(6)
2018
(9)
2017
(7)
2016
(6)
2015
(8)
2013
(4)
2012
(1)
2011
(1)
2010
(6)
2009
(2)
2006
(5)
2001
(1)
2000
(1)
45 results found
2014
∙
Haut Conseil de la santé publique
Notice relating to the immunisation schedule with the MenBvac® vaccine and to the potential revaccination with Bexsero®
2014
∙
Haut Conseil de la santé publique
Notice relating to the need to purse immunisation campaigns against clone B :14 :P1.7,16 in the French Departments of Seine-Maritime, Somme and Pyrénées-Atlantiques
2014
∙
Haut Conseil de la santé publique
Notice Update to the notice relating to antibiotic prophylaxis and meningococcal vaccination of persons treated with eculizumab (Soliris® 300mg concentrate for solution for infusion)
2014
∙
Haut Conseil de la santé publique
Notice Update to the notice relating to antibiotic prophylaxis and meningococcal vaccination of persons treated with eculizumab (Soliris® 300mg concentrate for solution for infusion)
2014
∙
Ministerio de Sanidad, Servicios Sociales e Igualdad
Reccommendation on the use of meningococcal B Vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register